BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B

BIO-RAD LABORATORIES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$352.82−0.88 (-0.25%)

Close on Oct 19, 2026

Dividends

No dividend per share appears in Bio-Rad Laboratories's annual filings since fiscal 2010.

Parsed from the XBRL in Bio-Rad Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 8, 2002
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIO.

Revenue growth1.4% · median 4.1%

Gross margin51.9% · median 46.4%

Operating margin2.1% · median 7.1%

Net margin8.6% · median 3.6%

Advertisement
300 × 250